MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
manilatimes10h
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
At Week 14, 69% (71% of b/tsDMARD-naïve and 66% of b/tsDMARD-experienced) or 220 of the 318 rosnilimab-treated patients across all doses achieved CDAI LDA and were eligible to remain on continued ...
Newsable Asianet News on MSN1d
From Period to Ovulation: How hormones influence your immune health
Essentially, hormonal changes that affect several physiological functions, including the immune system, result in a complex ...
Scientists Reprogram Immune Cells to Stop Autoimmune Attacks
A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...
manilatimes2d
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD
Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.
clinicaltrialsarena5d
Replicate’s rabies vaccine rivals Bavarian Nordic’s RavAlert at Phase I
The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
Experimental vaccine seems to battle advanced kidney cancers
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
studyfinds6d
Personalized vaccines halt kidney cancer after encouraging phase 1 trial
Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...
clinicaltrialsarena6d
BioNTech’s oncology vaccine trial sees all patients living kidney cancer-free
A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...